BN Business News
Add your company to Business Communicator →

Business · 02/02/2007

FDA Clears SUSTIVA 300mg Tablets for Approval

The FDA has ruled that SUSTIVA 300mg tablets were not withdrawn due to safety or effectiveness concerns, paving the way for potential approval of generic versions.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights